Clinical trial Recruiting at 1 site Interventional Ages 18 to 30 Men only

Oxytocin and real-time fMRI neurofeedback of the anterior insula

Official title: Effects of Intransal Oxytocin on Real-time fMRI Neurofeedback Training of Anterior Insula Activity Using an Interoceptive Strategy

Run by University of Electronic Science and Technology of China · NCT07559656 · Data updated 2026-11-12

This trial will test whether a single intranasal dose of oxytocin helps healthy men use interoceptive strategies to improve real-time fMRI neurofeedback targeting the anterior insula.

More Healthy Aging trials

Quick facts

Study typeInterventional
Ages18 Years to 30 Years
SexMen only
Enrollment80 (estimated)
SponsorUniversity of Electronic Science and Technology of China
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedApril 26, 2026
Main results expectedSeptember 27, 2026
Study endsOctober 1, 2026
Registry record updatedApril 30, 2026
Trial IDNCT07559656 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adult men without current or past psychiatric or neurological disorders who can safely undergo MRI and are willing to self-administer intranasal spray.

Probably not a fit

People with a history of brain injury, psychiatric or neurological illness, MRI contraindications, or women (who were not included) are unlikely to benefit from the findings of this specific trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind, placebo-controlled study enrolls 80 healthy male participants who self-administer either 24 IU intranasal oxytocin or placebo. All participants receive continuous real-time fMRI neurofeedback from the left anterior insula across four training sessions and one transfer session without feedback. Behavioral effects are measured with pain-empathy ratings after each block and interoceptive accuracy is measured with a heartbeat detection/counting task before and after training. Personality and interoception-related traits are assessed with validated questionnaires to explore individual differences in neurofeedback response.

Why it matters

Potential benefit: If successful, the approach could make it easier for people to learn to regulate anterior insula activity with neurofeedback, informing methods to enhance interoception and empathy-related brain function.

How similar studies have gone: Prior studies show oxytocin can alter social and interoceptive processing and separate rt-fMRI neurofeedback studies can change insula activity, but combining oxytocin with neurofeedback is novel with limited prior direct evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy subjects without any past or present psychiatric or neurological disorders.

Exclusion Criteria:

* History of brain injury medical or mental illness.
* Contraindication to MRI scanning (e.g., metal implants, claustrophobia or other --conditions that make them inappropriate for MRI scanning).

Where it's running

  • University of Electronic Science and Technology of China
    Chengdu, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.